Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA

Martina Ulrich,Uwe Reinhold,Rolf Dominicus,Roland Aschoff,Rolf-Markus Szeimies,Ruth Schäning,Marie-Theres Zeuner,Nicole Pospiech,Thomas Dirschka

DOI: https://doi.org/10.1016/j.pdpdt.2024.104280

IF: 3.577

2024-07-14

Photodiagnosis and Photodynamic Therapy

Abstract:Background Acral actinic keratosis (AK) lesions are considered difficult to treat, and published data for photodynamic therapy (PDT) on these lesions is limited. Thus, we evaluated sustained efficacy, safety, and satisfaction after PDT for AK on the hands. Methods We analysed subgroup data for treatment on the hands from a randomised, double-blind, intra-individual phase III study. All participants previously underwent up to two field-directed red light PDTs with 10% 5-aminolevulinic acid nanoemulsion gel (BF-200 ALA). Assessments included pain during PDT, clearance and recurrence rates, and satisfaction. Results 24 participants treated on the hands were included; 21 participants were analysed. Complete clearance rates with BF-200 ALA were 90.9% (lesion-based) and 76.2% (per participant's side), both markedly higher than with vehicle. The lesion recurrence rate with BF-200 ALA was 29.0%. Adverse events reflected the mode of action. Mean pain intensities were 4.8 ± 3.8 (BF-200 ALA) and 0.8 ± 2.1 (vehicle) on an 11-point numeric rating scale. Most participants (81.0%) rated their satisfaction with BF-200 ALA as very good or good. Conclusion This subgroup analysis indicates that PDT with BF-200 ALA provides a suitable treatment for AK lesions on the hands.

oncology